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Background: Management of aortic stenosis in elderly patients, especially when associated with complex comorbidities, has become an important 
issue. For these higher surgical risk patients, the role of percutaneous balloon aortic valvuloplasty (BAV) remains discussed. Overall improvements 
in techniques and hardware have made the procedure more efficient, fast and safe. We report the updated technique, indications and immediate 
results of BAV in our highly experienced center.
Methods: From May 2005 to Dec 2008, BAV was performed in 311 patients, 46% women, aged 81 ± 10years. BAV is performed under local 
anesthesia using the percutaneous retrograde approach. Through a 10 / 14F sheath, 20, 23, or 25mm size balloons (Cristal balloon, BALT / Z-MED 
II, NUMED) are advanced to the native valve over an extra-stiff wire. Initial balloon size is selected on annulus size, degree of valvular calcification 
and associated aortic regurgitation. Sequential increase in balloon size is often required. The goal is to increase the EOA by near 100% and decrease 
the mean gradient to < 25mmHg. Rapid right ventricular pacing (180 to 220bpm) is systematically used during balloon inflation. Percutaneous 
closure of the femoral approach is obtained with Angioseal / Perclose.
Results: The indications were as follows: bridge to AVR in severely depressed ventricular function (n=28), urgent BAV before non cardiac surgery 
(n=31), urgent BAV for cardiogenic shock (n=37), bridge to transcathter valve implantation (n=180), compassionate and other (n=35). EOA 
increased from 0.68 ± 0.25 to 1.14 ± 0.41cm2 (p<0.001) and mean gradient decreased from 44.0 ± 18.9 to 19.9 ± 10.8mmHg (p<0.001). Ten 
patients (3.2%) died: 4 during the procedure(1.3%). Twenty patients (6.4%) had non fatal in-hospital complications: 6 TIA or stroke (1.9%), 4 aortic 
regurgitation ≥ grade3 (1.3%), 4 complete A-V block (1.3%) and 6 surgical vascular complication (1.9%).
Conclusion: BAV has become much simpler and safer in spite of being applied in severely ill patients. This technique remains indicated in various 
situations, with an emerging indication in highly symptomatic / life threatened patients on the waiting list for transcatheter heart valve implantation.
